Investigating how cell junctions in the eye affect pressure and glaucoma risk
Does VECAD at Schlemm canal cell-junctions determine IOP and glaucoma risk?
This study is looking at how certain connections between cells in the eye affect eye pressure, which is important for people with glaucoma, by using special mice to learn more about how these connections work and how problems with them might lead to glaucoma, with the hope of finding better treatments for the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11005709 on NIH RePORTER |
What this research studies
This research focuses on understanding how certain cell junctions in the eye, particularly in Schlemm's canal, influence intraocular pressure (IOP), which is a key factor in glaucoma. By studying mutant mice, the researchers aim to uncover the molecular pathways that regulate IOP and how abnormalities in these pathways can lead to glaucoma. The project seeks to provide new insights into the biology of aqueous humor drainage and the role of specific proteins in maintaining normal pressure levels in the eye. Ultimately, this work could lead to the development of more effective treatments for glaucoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for glaucoma or those with elevated intraocular pressure.
Not a fit: Patients who do not have elevated intraocular pressure or a family history of glaucoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that more effectively lower intraocular pressure and reduce the risk of glaucoma.
How similar studies have performed: Previous research has shown promise in understanding the mechanisms of intraocular pressure regulation, but this specific approach focusing on VECAD and cell junctions is relatively novel.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: John, Simon W — Columbia University Health Sciences
- Study coordinator: John, Simon W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.